期刊
MOLECULAR PHARMACOLOGY
卷 73, 期 1, 页码 178-190出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.107.039842
关键词
-
资金
- NIDA NIH HHS [R01 DA007339, K05 DA000513-07, DA011806, R56 DA000564, DA007339, R01 DA007339-17, R01 DA016674, P50 DA011806, DA016674, K05-DA00513, K05 DA000513, K05-DA70544, DA000564, R01 DA016674-04, R01 DA000564] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [R56DA000564, R01DA007339, R01DA000564, R01DA016674, K05DA000513, P50DA011806] Funding Source: NIH RePORTER
The cellular location of extracellular signal-regulated kinases (ERKs) activated by a G protein-coupled receptor was shown to be dependent on the pathway that mediated their activation. In general, fast activation of ERKs (2 min) mediated by G proteins resulted in the nuclear translocation of phosphorylated ERKs, whereas a slower activation of ERKs (10 min) mediated by beta-arrestins resulted in the cytosolic retention of the phosphorylated ERKs. However, we observed distinct differences from this established ERKs cellular itinerary with the mu-opioid receptoractivated ERKs. Agonists such as morphine and methadone activated ERKs via the protein kinase C-dependent pathway but not the beta-arrestin-dependent pathway. The activated ERKs did not translocate into the nucleus, but phosphorylated 90-kDa ribosomal S6 kinase and induced the activity of transcription factor cAMP response element-binding protein. In contrast, agonists such as etorphine and fentanyl activated ERKs in a beta-arrestin-dependent manner. The phosphorylated ERKs translocated into the nucleus, resulting in increases in Elk-1 activity and GRK2 and beta-arrestin2 transcriptions. Thus, the cellular location of phosphorylated ERKs and subsequent activities on gene transcriptions are dictated by the agonist used to activate the receptor and the subsequent signaling pathway involved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据